Latest news with #RamKapoor
NDTV
a day ago
- Entertainment
- NDTV
Bigg Boss 19: From Ram Kapoor To Mallika Sherawat, Celebrities Who Refused To Be A Part Of The Reality Show
New Delhi: One of the most beloved reality shows, Bigg Boss, is all set to return with season 19. Lately, there has been a lot of buzz regarding the contestants in Big Boss 19. Hosted by Salman Khan, the reality show was initially expected to have some well-known television personalities like Ram Kapoor, Munmun Dutta, and digital star Mr Faisu as contestants. Additionally, Dheeraj Dhoopar, Anita Hassanandani, Ashish Vidyarthi, Apoorva Mukhija, Gaurav Taneja, Kanika Mann, Krishna Shroff, Raj Kundra, and Sreerama Chandra were also believed to be considered for this season of Bigg Boss. Along with the regular contestants, it is reported that Kavya Mehra, India's AI Influencer, is also in talks to be a part of Bigg Boss 19. However, here's a look at some of the well-known names who have firmly refused to be a part of the upcoming season. Ram Kapoor While th e Mistry actor has been embroiled in a lot of controversies lately, he revealed his decision to never join the Big Boss House recently. In a conversation with Filmibeat, the actor had stated that he wouldn't be a part of the show even if he was given Rs 20 crore. He called the show "voyeuristic" and also stated how it does not align with the kind of perception he has as an actor, along with privacy concerns. View this post on Instagram A post shared by Ram Kapoor (@iamramkapoor) Mallika Sherawat On Monday, Mallika shared a note on her Instagram Stories, which read, "Putting an end to all the rumours, I am NOT doing Bigg Boss and NEVER WILL. THANK YOU." The actress earlier attended Bigg Boss 18 as a guest to promote her film Vicky Vidya Ka Woh Wala Video. View this post on Instagram A post shared by Mallika Sherawat (@mallikasherawat) Zareen Khan Zareen Khan of Veer fame revealed in an interaction with Hindi Rush that she did not want to be a part of Big Boss because of practical and personal reasons. She also explained how she could not bear to be away from home for three months, as she had responsibilities. She also stated that she will be evicted from the house as she won't tolerate misbehaviour, " Mera haath uth jayega." View this post on Instagram A post shared by Zareen Khan 🦄🌈✨👼🏻 (@zareenkhan) Anita Hassanandani In an interview with Pinkvilla, Anita Hassanandani stated how she didn't think she was wired to be a part of a reality show like Big Boss. She was also honest, as she remarked that even if she agreed, the makers would not be able to get the kind of drama the show needs out of her. View this post on Instagram A post shared by Anita H Reddy (@anitahassanandani) Anshula Kapoor Anshula Kapoor, Arjun Kapoor's sister, was recently a part of the hit reality show The Traitors. According to Siaset, she would not be able to cope with the "intense format" of the show and hence declined the offer. View this post on Instagram A post shared by Anshula Kapoor (@anshulakapoor) Raj Kundra Interestingly, both Shilpa Shetty and Shamita Shetty have been part of the Big Boss franchise. Shilpa Shetty had hosted the second season of Big Boss in 2008. Shamita Shetty was a part of Bigg Boss 3, which she left midway to attend her sister's wedding. She then went on to become a part of Bigg Boss OTT and Bigg Boss 15. Raj Kundra mentioned that he thinks that's enough. X/Raj Kundra Purav Jha He was one of the traitors in the first season of the popular reality show The Traitors. However, he declined the offer to be a part of Big Boss for now. He hasn't ruled out the possibility completely. View this post on Instagram A post shared by Purav Jha (@puravjha) Jannat Zubair The actress had two reasons not to be a part of Big Boss Season 19. One being that she did not want to deal with too much drama right now. Reports also suggest that there is a possibility of an ex-boyfriend being one of the participants. View this post on Instagram A post shared by Jannat Zubair Rahmani (@jannatzubair29) Khan Sir He is extremely popular for his unique teaching style and has a massive YouTube fan following. It was during one of his teaching classes that he revealed that he had been approached to be a part of Big Boss before, and this year, too, he was offered to join. A viral video making the rounds online saw Khan Sir telling his students, " Bigg Boss waale baar baar bula rahe hain. Lekin maine har baar mana kar diya." When students teased him, he ended on a funny note that they might ask him to do live classes from the Big Boss sets. YouTube This season of Bigg Boss is expected to have 15 contestants at the beginning, with around 3 to 5 wild card entries during the course of the show. Bigg Boss 19 is set to premiere by late August. While the exact premiere date and contestant list for Bigg Boss 19 have not been unveiled till now, the announcement has definitely added to the buzz for the latest season of the show.
Mint
3 days ago
- Health
- Mint
From Wegovy to Ozempic: Which drugs are really APPROVED for weight loss in India, how costly are they?
Lost 120 kgs in 16 months, 55 kgs in 18 months, 20kgs in XX months and so the era of being 'fit and fine', the remarkable weight loss journey of several TV and film stars has left many wondering: Have they used any weight loss drug? Actor Ram Kapoor, producers Boney Kapoor and Sajid Nadiadwala, and rapper Badshaah are the latest to join the league.. The reasons they claimed for their weight loss were more or less the same: a balanced diet, discipline, exercise, and making some lifestyle changes. But their exceptional transformation led to speculation that they used blockbuster drugs like Novo Nordisk's Ozempic or Wegovy. Not just these, but many other anti-obesity drugs have entered the Indian market. Ozempic has not been officially launched in India. The market for weight-loss drugs in India is experiencing rapid growth. According to research firm Pharmarack, as cited by the Economic Times, the Indian anti-obesity drug market has seen substantial growth, reaching ₹ 628 crore as of June 2025, a fivefold increase over five years. Danish drugmaker Novo Nordisk and US-based rival Eli Lilly have seen skyrocketing demand for their obesity drugs Wegovy and Zepbound. The market is estimated to grow to $150 billion globally by the early 2030s. How many anti-obesity drugs are available in India? How much do they cost? Are they really approved for weight loss? And do they help in weight loss? Here's all you need to know: Six weight-loss drugs have been approved by the U.S. Food and Drug Administration (FDA) for long-term use: Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Xenical, Alli) Phentermine-topiramate (Qsymia) Semaglutide (Wegovy) Setmelanotide (Imcivree) Tirzepatide (Zepbound) There are many drugs that are have not been licensed for the treatment of obesity. Tirzepatide: According to a reasearch paper in the International Journal of Life Sciences, Biotechnology and Pharma Research, Tirzepatide was approved by the Central Drug Standard Control in India recently in June 2024. Oral Semaglutide: According to Medanta, Oral Semaglutide is approved and available in India for use in type-2 diabetes and obesity only. Wegovy: Another injectable semaglutide Wegovy has been approved for weight loss in case of obesity without type-2 diabetes, and is available in India. It wa launched in India on June 24. Ozempic: Injectable semaglutide Ozempic is "not approved or available in India." Mounjaro: India's drug regulator has approved the launch Eli Lilly's weight-loss drug, Mounjaro, Reuters reported on June 26, 2025. It's once-weekly injectable featuring tirzepatide. Mounjaro's active ingredient, tirzepatide, has captured 8 percent of the market in India, Pharmarack said. Is Mounjaro approved for weight loss? No, Mounjaro isn't approved by the US FDA directly. However, its active ingredient, tripeptide, is approved for weight loss under the brand name Zepbound. But, in India, Mounjaro KwikPen has been approved by the Central Drugs Standard Control Organisation for six dose strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, the company was quoted by Reuters as saying. Cost in India: The drug is priced at ₹ 3,500 for a 2.5 mg vial and ₹ 4,375 for a 5 mg vial, the Hindu reported. Mounjaro, usually taken once a week, would then cost between ₹ 14,000 and ₹ 17,500 per month, depending on the dosage recommended by the doctor. The average monthly price of Mounjaro in the US. is about $1,000 to $1,200 (approximately ₹ 86,000 to ₹ 1 lakh). Rybelsus is used for diabetes treatment. It was introduced in India in 2022 as an oral drug and is hailed as a breakthrough in Type 2 diabetes treatment. Rybelsus contains the active substance semaglutide. Has Rybelsus been approved for weight loss? No. It has not been approved for weight loss. But the company claims it may help one lose some weight. "While many people in medical studies lost weight, some did gain weight," the company's website claimed. Cost in India: Rybelsus is available as tablets (3, 7 and 14 mg) and can only be obtained with a prescription. The monthly cost comes to approximately ₹ 10,000, Business Standard reported. Wegovy's active ingredient is semaglutide, and it dominates the market with a two-thirds share in India. Is Wegovy approved for weight loss? Yes, Wegovy is FDA-approved for weight loss, but only if you are above a certain weight. This once-weekly injectable weight loss treatment exclusively for chronic weight management is available in five strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. The FDA says Wegovy is approved to "reduce excess weight and maintain weight reduction long term in certain adults with obesity or overweight and certain children with obesity, for use in addition to a reduced calorie diet and increased physical activity." COST: The cost of Wegovy in India ranges from ₹ 17,345 to ₹ 26,015 per month, depending on the dosage. -0.25 mg to 1 mg doses: ₹ 17,345/month -1.75 mg dose: ₹ 24,280/month -2.4 mg dose: ₹ 26,050/month This translates to roughly ₹ 4,366 per injection for the highest dose, as per Indian generic drugmakers, including Cipla, Dr Reddy's, Lupin and Cipla, have been racing to produce cheaper versions of Wegovy when semaglutide goes off patent in 2026. Semaglutide's patent is expected to expire in several countries next year, including in India in March. Semaglutide is the active ingredient of blockbuster drugs Wegovy and diabetes medicine Ozempic. Novo Nordisk, which says it controls about 70% of the global market for these drugs, will lose exclusivity in many markets from 2026, with patents in India expiring around April of next year. That patent expiration does not include the US, Europe or Japan. There are several local and international drugmakers eyeing the Indian market. They are: Dr Reddy's, which aims to launch a cheaper copycat version of Wegovy in 87 countries next year, says its strategy is to target countries where Novo Nordisk does not hold patents for semaglutide. Dr Reddy's initially plans to launch the generic version of semaglutide in Canada, India, Brazil, Turkey and other emerging markets, subject to patent expiry, Israeli was quoted by Reuters as saying. Biopharmaceutical company Biocon also plans to submit a request for approval to India's drug regulator by the end of 2026 and potentially launch in 2027 through a partner, CEO Siddharth Mittal told Reuters in an email interview. There are 'Prescription Medications' and 'off-label' medications which used in a way that's different from what the FDA has approved. 'Off-label' medication can be a: 'a drug approved for treating a different medical problem; two or more drugs at the same time; a drug for a longer time period than approved by the FDA,' as stated by the National Institute of Diabetes and Digestive and Kidney Diseases. It says weight management medications aren't for everyone with a high Body Mass Index (BMI). Obesity is defined as having a BMI of 30 or greater. It has been warned that while some anti-obesity drugs can be effective for weight loss, they may also carry potential risks and side effects, and their long-term safety is still being evaluated. A research paper published in September 2024 says that the effectiveness of Tirzepatide (used in Mounjaro) in reducing weight was superior to other drugs. 'But mild to moderate Gastrointestinal symptoms were present which were dose dependant and subsequently subsided,' it said. "Rarely, serious side effects can happen. That's why it's important to ask your health care provider about all treatment choices," Mayo Clinic says. "These drugs aren't for everyone," Mayo Clinic says. It advises one must not take prescription weight-loss drugs if you're trying to get pregnant, are pregnant or are breastfeeding. Besides, weight-loss drugs can be expensive and aren't always paid for by insurance. 1. Nausea, vomiting would be the most common side effects of Semaglutide in clinical practice. 2. Loose motions are rare, but are a common reason for not being able to tolerate the drug. 3. Headache not responding to conventional pain medicines. The incidence of obesity and diabetes is rising in India, which ranks among the worst three globally for high obesity rates, according to a study published in the medical journal The Lancet. As per the National Family Health Survey (NFHS)-5 (2019-21), overall, 24% of Indian women and 23% of Indian men are overweight or obese
Economic Times
4 days ago
- Entertainment
- Economic Times
Bigg Boss 19 teaser out with new logo: What is different this season as rumoured contestants stir buzz
Agencies Bigg Boss 19's teaser is out, revealing a 'Rewind' theme and a vibrant new eye logo, signaling a season of major changes. Salman Khan is expected to host the show, which premieres in late August 2025. The wait is finally over! The teaser for Bigg Boss 19 has officially been unveiled, setting off a wave of excitement among fans. With a kaleidoscopic new eye logo and a cryptic theme titled "Rewind," the upcoming season promises a major reset, both in format and flair. As always, Salman Khan is expected to return as host, adding his signature gravitas and unpredictability to the reality juggernaut. The show is slated to premiere in late August 2025, though the exact date remains under wraps. The teaser, released by JioCinema and Viacom18, features the revamped eye symbol—a striking multicolour emblem that nods to the layered chaos, energy, and drama the show is known for. 'Countdown hogaya hai shuru, hoga chaos unlock soon! Stay tuned,' reads the caption shared across official social media platforms. According to IANS, the logo reflects the 'untamed energy and attitude' viewers can expect this season, with several 'surprises' reportedly in store. Though the final list is still under wraps, the rumour mill is churning at full speed. A flurry of names from across the entertainment spectrum are being speculated—actors, influencers, fitness coaches, and even an AI influencer. Here's a look at some of the big names reportedly in talks: Ram Kapoor & Gautami Kapoor: The real-life couple might be walking into the Bigg Boss house together, raising the stakes for relationship dynamics. Mr. Faisu: The digital sensation and influencer is rumoured to make a splash after his stint on Celebrity MasterChef. Munmun Dutta (aka Babitaji), Anita Hassanandani, and Dheeraj Dhoopar: Familiar faces from Indian television are reportedly in the mix. Krishna Shroff: The fitness enthusiast and reality TV regular could bring a strong competitive edge. Raj Kundra: After The Traitors, Shilpa Shetty's husband may be gearing up for more on-screen drama. Tanushree Dutta, Sharad Malhotra, and Paras Kalnawat: Each a newsmaker in their own right, these actors may add gravitas and emotional layers to the season. From digital creators like Apoorva Mukhija, Gaurav Taneja (Flying Beast), Purav Jha, and Micky Makeover, to emerging stars like Khushi Dubey and Alisha Panwar, the casting seems designed to reflect the diversity of Indian pop culture today. Notably, as per reports AI influencer Kavya Mehra is also in talks to enter the Bigg Boss house According to SCREEN, the 'Rewind' theme is expected to bring back nostalgic elements like the 'Secret Room,' where nominated contestants might secretly watch the game unfold. But in a bold shift, audience voting could determine nominations, while eviction decisions may lie with contestants themselves—adding an unpredictable twist to the game this season will be split into two phases: a televised run of about four months, followed by an OTT-exclusive continuation. The show will air on Viacom18 channels and stream on JioCinema, produced by Banijay yes—rations are back in play. Failed tasks may lead to a week of empty plates, echoing the show's old-school survival drama fans gear up for the storm of emotions, controversies, alliances, and drama that Bigg Boss is known for, all eyes are on official announcement for the final premiere date and cast.
News18
5 days ago
- Entertainment
- News18
Ekta Kapoor's ALTT Banned: 5 Of Its Most Popular Shows
1/7 ALLT, formerly ALTBalaji, has been banned by the central government, for allegedly hosting obscene, vulgar, and adult content. Apart from ALTT, 24 other apps and websites have been cracked down. (Image: IMDb) Karrle Tu Bhi Mohabbat: This was the first show of ALTT. Starring Ram Kapoor and Sakshi Tanwar, it was about two opposite people falling in love. (Image: IMDb) Ragini MMS: Returns: The found-footage erotic horror web series was the third installment of Ragini MMS franchise. (Image: IMDb) Gandii Baat: This was an adult comedy web series, which had a total of seven seasons. (Image: IMDb) 6/7 Broken But Beautiful: The romance OTT series featured names like Vikrant Massey, Harleen Sethi, Sidharth Shukla, and Sonia Rathee. (Image: IMDb) Code M: The crime drama series revolves around an Indian Army lawyer. It starred Jennifer Winget, Rajat Kapoor, Seema Biswas, and Tanuj Virwani. (Image: IMDb)
Indian Express
5 days ago
- Health
- Indian Express
Should you skip dinner after your 40s? Gut doctor on why you should junk celebrity chatter on fasting and one-meal diets
Most personal health conversations between peers and on social media focus on skipping dinner or just having that one big meal a day, particularly for those above 40. The logic is your metabolism slows down by the end of the day and the body can very well do without the third meal. Celebrities, from Karan Johar, Ram Kapoor and Raveena Tandon, have credibilised this view on social media, touting their individual case histories as proof that a diet fad works. Fact is, the concept of dinner evolved because of a reason. 'Every meal has its importance and so has dinner. It's the last major meal of the day and is needed by everybody, whether you are 20 or 50. There's no ageism here. It gives your body the calories and nutrients it needs to ride out the longest hours it goes without food. If we are to synchronise our lifestyle with the body's natural sleep-wake cycle or the circadian rhythm, then we ought to provision for the body's functions at rest. Yet most people these days drop dinner, disregarding its nutrition value,' says Dr Sudeep Khanna, gastroenterologist and GI medicine specialist at Indraprastha Apollo Hospitals, Delhi. This is the biggest myth there is. The body doesn't stop working while sleeping and needs calories to perform its basic functions. Dinner fuels your body for these tasks. Without calories, your body can slow down to conserve energy. This is what slows down metabolism, not the dinner itself. And slower metabolism can lead to weight gain. Sometimes the body cannot adjust to this denial and may have an extremely strong late night craving. That's what leads to 2 am eating binges. Late-night eating can lead to increased hunger and decreased leptin, a hormone that signals satiety, and may raise your risk for obesity. The only rule to be followed about dinner is that you must have it early, by 7.30 pm, to ensure a decent three hour gap before sleeping and a 10-12 hour gap before your next meal or breakfast. This way we can ensure steady calorie burns. And if you want to perk up your metabolism, make sure you exercise enough. It has a negative impact, especially given the burden of non-communicable diseases like diabetes and heart disease that Indians are vulnerable to. It can lead to fluctuations in blood sugar, with sudden dips and highs, which can harm people with diabetes. It can leave you feeling exhausted. A 2023 study in the Journal of the Academy of Nutrition and Dietetics showed how eating just one meal a day was linked to a higher mortality risk and skipping lunch or dinner specifically increased the risk of cardiovascular disease. And since you asked about people over 40 not requiring dinner, let me tell you that another study in 2020 had shown how skipping meals plunged older adults deeper into depression, anxiety and insomnia. A recent Harvard study has found that sticking to a healthy diet in midlife has a direct impact on healthy ageing. The research, based on data from over 100,000 people spanning 30 years, revealed that people who followed a healthy diet from their 40s onward were 43-84% more likely to be well-functioning physically and mentally at age 70 compared with those who did not. If you're not eating regular meals, you may miss out on essential vitamins and minerals needed for overall health and well-being. Look at your dinner plate. Remove the refined carbs and focus on proteins and greens. Post 40s and 50s, our muscles start degenerating fast. So we need more protein to replace the muscle loss, at least 1 gm per kg of body weight. I have seen people weighing 75 to 80 kg but their plates don't match their protein requirement. Choose fibrous fruits, vegetables, legumes, whole grains and healthy fats.
